Personal profile
Link to Utrecht University staff page
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Patrick Souverein is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Publication network from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Concordance of Lung Cancer, Melanoma, and Renal Cell Cancer Diagnosis Information Recorded in Health Care Databases in England: Analysis of Linkage Between Primary Care, Hospital Care, and Cancer Registry Data
Kruithof, P. D., Souverein, P. C., Driessen, J. H. M., Hendriks, L. E. L., Croes, S. & van Geel, R. M. J. M., Jan 2026, In: Pharmacoepidemiology and Drug Safety. 35, 1, e70299.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
Early Identification of Cardiovascular Adverse Events Associated With Rofecoxib Using Real-World Data From the UK: A Nested Case-Control and Case-Crossover Study
Moslemzadeh, D., Souverein, P. C., Belitser, S. V., Heerdink, E. R., Klungel, O. H. & Abtahi, S., 9 Mar 2026, In: Pharmacoepidemiology and Drug Safety. 35, 3, e70343.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
Implementation of OMOP and ConcePTION Common Data Models in CPRD GOLD: Risk of Bleeding and Cardiovascular Outcomes From Anticoagulant Use
Hunt, N. B., Souverein, P., Bazelier, M., Barclay, N., Delmestri, A., Sturkenboom, M., Prieto-Alhambra, D., Gardarsdottir, H. & Klungel, O., 2026, (E-pub ahead of print) In: Clinical Pharmacology and Therapeutics.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Standardisation of terminology, calculation and reporting for assigning exposure duration to drug utilisation records from healthcare data sources: the CreateDoT framework
Riera-Arnau, J., Paoletti, O., Gini, R., Thurin, N. H., Souverein, P. C., Abtahi, S., Durán, C., Pajouheshnia, R. & Roberto, G., 19 Feb 2026, medRxiv, 36 p.Research output: Working paper › Preprint › Academic
-
Applying two approaches to detect unmeasured confounding due to time-varying variables in a self-controlled risk interval design evaluating COVID-19 vaccine safety signals, using myocarditis as a case example
Bots, S. H., Belitser, S., Groenwold, R. H. H., Durán, C. E., Riera-Arnau, J., Schultze, A., Messina, D., Segundo, E., Douglas, I., Carreras, J. J., Garcia-Poza, P., Gini, R., Huerta, C., Martín-Pérez, M., Martin, I., Paoletti, O., Bissacco, C. A., Correcher-Martínez, E., Souverein, P. & Urchuequía, A. & 3 others, , Jan 2025, In: American Journal of Epidemiology. 194, 1, 12 p., kwae172.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile
Activities
- 2 Invited talk
-
Ace-inhibitor use and decreased pneumonia risk in elderly patients with diabetes
Souverein, P. (Invited speaker)
2006Activity: Talk or presentation › Invited talk › Academic
-
Statin therapy and reduced risk of pneumonia in senior
Souverein, P. (Invited speaker)
2006Activity: Talk or presentation › Invited talk › Academic